transplant infection disease - Yahoo News Search Results
Astellas And Vical Begin Phase 2 Trial Of ASPO113 Vaccine
Astellas Pharma Global Development, Inc. and Vical Inc. have begun a Phase 2 trial of ASP0113 in approximately 140 solid organ transplant (SOT) recipients. ASP0113 (formerly TransVaxä) is an investigational bivalent DNA vaccine containing plasmids (closed loops of DNA) that induce both cellular and humoral immune responses. The vaccine has previously received orphan drug designation in the ...
Astellas and Vical Announce Initiation of Phase 2 Trial of ASP0113, a Cytomegalovirus Vaccine, in Solid Organ ...
NORTHBROOK, Ill. and SAN DIEGO, Dec. 10, 2013 /PRNewswire/ -- Astellas Pharma Global Development, Inc., a subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo:4503), and Vical Incorporated (VICL) today announced the initiation of a Phase 2 trial of ASP0113 in approximately 140 solid organ transplant (SOT) recipients. The global, randomized, double-blind, placebo-controlled trial is designed to ...
NC double lung transplant grateful to be alive
LINDEN, N.C. (AP) — A year after she received a lung transplant, Peggy Winschel can find the breath, but not the words, to thank the person who died to save her life.
HIV Can Infect Transplanted Kidneys in HIV-Positive Recipients with Undetectable Virus
* HIV infection occurred in 68% of the HIV-positive transplant recipients' new kidneys even in the absence of any detectable HIV in their blood. * A new urine test can detect these infections and lead to better diagnosis and treatment
MassBiologics gets FDA orphan drug designation for MBL-HCV1 antibody
MassBiologics of the University of Massachusetts Medical School has received an orphan drug designation from the U.S. Food and Drug Administration for MBL-HCV1, a monoclonal antibody developed to prevent hepatitis C virus recurrence in patients receiving a liver transplant.
MassBiologics receives orphan drug status from FDA for hepatitis C treatment
( University of Massachusetts Medical School ) MassBiologics of the University of Massachusetts Medical School has received an orphan drug designation from the US Food and Drug Administration for MBL-HCV1, a monoclonal antibody developed to prevent hepatitis C virus recurrence in patients receiving a liver transplant.
How safe is donated blood? Inquiry is launched amid fears of infection from human form of mad cow disease
The Commons Science and Technology Committee has called for an inquiry after studies revealed one in every 2,000 Britons could be carrying vCJD.
Inquiry into donor blood vCJD risk
An inquiry is being launched to check the safety of donor blood amid concerns about an infection risk from the human form of "mad cow disease".
Father donates organ to daughter; Govt can cut cost significantly
Bandar Seri Begawan: A medical milestone was reached in Brunei Darussalam on November 21, 2013 when the first ever kidney transplant was carried out at Raja Isteri Pengiran Anak Saleha (RIPAS) Hospital.
Research and Markets: Chicago Infectious Disease Board Review
Research and Markets has announced the addition of the "Chicago Infectious Disease Board Review" training to their offer